100 related articles for article (PubMed ID: 483232)
1. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
Breddin K; Loew D; Lechner K; Uberla K; Walter E
Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
[No Abstract] [Full Text] [Related]
2. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K; Loew D; Lechner K; Oberla K; Walter E
Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
[TBL] [Abstract][Full Text] [Related]
3. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
Weber E; Walter E; Pfleiderer T
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
[No Abstract] [Full Text] [Related]
4. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
Walter E; Weber E; Loew D
Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
[No Abstract] [Full Text] [Related]
5. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
Breddin HK; Uberla KK
Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
[No Abstract] [Full Text] [Related]
6. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.
Breddin K; Loew D; Lechner K; Uberla K; Walter E
Haemostasis; 1980; 9(6):325-44. PubMed ID: 7005035
[No Abstract] [Full Text] [Related]
7. Statistical evidence of the German-Austrian secondary prevention trial.
Uberla K
Thromb Haemost; 1979 Feb; 41(1):237-41. PubMed ID: 483233
[No Abstract] [Full Text] [Related]
8. [Prevention of reinfarction with acetylsalicylic acid].
Vogel G; Fischer C; Huyke R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):797-803. PubMed ID: 94871
[TBL] [Abstract][Full Text] [Related]
9. On the interaction between the anti-inflammatory substance proquazone (RU 43-715) and phenprocoumone.
Vinazzer H
Int J Clin Pharmacol Biopharm; 1977 May; 15(5):214-6. PubMed ID: 326688
[TBL] [Abstract][Full Text] [Related]
10. [How long should antithrombotic therapy be continued following aortocoronary bypass surgery?].
Pfisterer M; Jockers G; Regenass S; Schmitt HE; Grädel E; Burkart F
Schweiz Med Wochenschr; 1989 Oct; 119(43):1518-20. PubMed ID: 2692145
[TBL] [Abstract][Full Text] [Related]
11. [Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of thrombocyte function inhibitors].
Breddin K
Internist (Berl); 1980 Jul; 21(7):394-6. PubMed ID: 7007279
[No Abstract] [Full Text] [Related]
12. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
Angelkort B
Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
[TBL] [Abstract][Full Text] [Related]
13. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
Harenberg J; Haas R; Zimmermann R
Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis in patients with cerebral ischemia treated with short term anticoagulant therapy -- a controlled trial (author's transl)].
Gallhofer B; Ladurner G; Lechner H
Fortschr Neurol Psychiatr Grenzgeb; 1980 Aug; 48(8):409-14. PubMed ID: 6902691
[No Abstract] [Full Text] [Related]
15. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
Circulation; 1980 Dec; 62(6 Pt 2):V79-84. PubMed ID: 7438383
[TBL] [Abstract][Full Text] [Related]
16. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
Fortschr Med; 1980 Aug; 98(32):1227-8. PubMed ID: 7409723
[No Abstract] [Full Text] [Related]
17. European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
Eur Heart J; 1984 Mar; 5(3):189-202. PubMed ID: 6373264
[TBL] [Abstract][Full Text] [Related]
18. [Experiences from general practice: use of acetylsalicylic acid and anticoagulants in patients following acute myocardial infarct].
Dahn G; Kothe K
Z Gesamte Inn Med; 1990 Aug; 45(15):439-41. PubMed ID: 2247990
[TBL] [Abstract][Full Text] [Related]
19. [Study on secondary prevention of myocardial infarct (EPSIM). Work of the EPSIM research group].
Arch Mal Coeur Vaiss; 1982 Dec; 75 Spec No():1-130. PubMed ID: 6820624
[No Abstract] [Full Text] [Related]
20. Interaction of allopurinol with phenprocoumon in man.
Jähnchen E; Meinertz I; Gilfrich HJ
Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
